Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 16 12:27PM ET
141.23
Dollar change
-0.16
Percentage change
-0.11
%
Index- P/E48.77 EPS (ttm)2.90 Insider Own0.02% Shs Outstand3.38B Perf Week0.57%
Market Cap471.49B Forward P/E33.73 EPS next Y4.19 Insider Trans0.00% Shs Float3.34B Perf Month-0.88%
Income12.98B PEG17.42 EPS next Q0.73 Inst Own9.73% Short Float0.14% Perf Quarter13.99%
Sales35.52B P/S13.28 EPS this Y23.66% Inst Trans-2.73% Short Ratio1.19 Perf Half Y31.79%
Book/sh3.21 P/B43.97 EPS next Y24.79% ROA32.56% Short Interest4.52M Perf Year76.38%
Cash/sh0.40 P/C350.03 EPS next 5Y2.80% ROE99.99% 52W Range77.96 - 148.15 Perf YTD36.52%
Dividend Est.1.61 (1.14%) P/FCF50.77 EPS past 5Y16.48% ROI77.53% 52W High-4.67% Beta0.41
Dividend TTM1.37 (0.97%) Quick Ratio0.50 Sales past 5Y14.25% Gross Margin84.65% 52W Low81.17% ATR (14)3.09
Dividend Ex-DateMar 22, 2024 Current Ratio0.70 EPS Y/Y TTM52.89% Oper. Margin45.00% RSI (14)50.79 Volatility1.91% 1.79%
Employees63370 Debt/Eq0.27 Sales Y/Y TTM34.74% Profit Margin36.56% Recom1.88 Target Price144.22
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q30.72% Payout36.03% Rel Volume0.46 Prev Close141.39
Sales Surprise2.61% EPS Surprise8.33% Sales Q/Q23.66% EarningsAug 07 BMO Avg Volume3.80M Price141.23
SMA20-0.75% SMA502.71% SMA20020.03% Trades Volume835,084 Change-0.11%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $156
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Today 09:00AM
07:00AM
Jul-15-24 01:00PM
11:42AM
08:20AM
06:50AM Loading…
06:50AM
Jul-14-24 06:31AM
05:20AM
Jul-13-24 05:52PM
09:00AM
05:30AM
Jul-12-24 04:06PM
01:37PM
11:05AM
08:01AM
08:00AM Loading…
08:00AM
07:07AM
06:15AM
05:00AM
Jul-11-24 06:07PM
01:50PM
12:46PM
12:13PM
12:09PM
11:30AM
11:11AM
11:09AM
10:48AM
07:58AM
07:55AM
06:44AM Loading…
06:44AM
Jul-10-24 05:45PM
05:02PM
02:34PM
01:53PM
06:35AM
06:03AM
Jul-09-24 02:02PM
12:59PM
12:39PM
11:58AM
11:47AM
10:44AM
09:57AM
09:51AM
09:33AM
07:34AM
06:42AM
06:25AM
05:40AM
Jul-08-24 05:45PM
04:02PM
12:32PM
11:53AM
09:18AM
01:00AM
Jul-06-24 08:00AM
08:00AM
Jul-05-24 03:15PM
12:28PM
09:42AM
05:50AM
05:45AM
Jul-04-24 06:35AM
Jul-03-24 03:03PM
02:46PM
12:41PM
12:35PM
12:17PM
11:53AM
11:52AM
08:24AM
08:00AM
07:55AM
Jul-02-24 05:07PM
04:35PM
04:09PM
04:01PM
03:53PM
02:02PM
01:15PM
12:25PM
11:54AM
11:40AM
11:38AM
11:33AM
11:12AM
06:24AM
Jul-01-24 10:02AM
09:19AM
07:45AM
01:00AM
Jun-30-24 04:38PM
09:15AM
Jun-29-24 06:04PM
06:03PM
11:34AM
Jun-28-24 06:00AM
Jun-27-24 05:45PM
05:09PM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.